一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

優(yōu)惠券使用說(shuō)明>

暫無(wú)可領(lǐng)優(yōu)惠券

凱立德生物醫(yī)藥技術(shù)(上海)有限公司

主營(yíng)產(chǎn)品:醫(yī)藥中間體及合成砌塊,藥物雜質(zhì)和衍生物,篩選化合物&小分子化合物,多肽,天然產(chǎn)物化合物等。

客服熱線:021-58180488

  • 手機(jī):
  • 電話:021-58180488 
  • 郵箱:sales@MedChemLeader.com
  • 網(wǎng)址:http://www.Medchemleader.cn
  • 地址:中國(guó)(上海)自由貿(mào)易試驗(yàn)區(qū)臨港新片區(qū)新楊公路1666號(hào)3幢
  • 企業(yè)認(rèn)證:
  • CB指數(shù):58

凱立德生物產(chǎn)品線之——雷公藤系列!

發(fā)布日期:2020/1/3 16:29:36發(fā)布人:凱立德生物醫(yī)藥技術(shù)(上海)有限公司閱讀量:239

凱立德生物產(chǎn)品線之——雷公藤產(chǎn)品系列!   

貨號(hào)
CAS No.
英文名
中文名
C10381
34157-83-0
Celastrol(Tripterin); tripterine; (2R,4aS,6aS,6aR,14aS,14bR)-10-Hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid; (9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid; 3-Hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid; 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid; NSC70931; 10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid
雷公藤紅素;南蛇藤素;南蛇藤醇
C11845
1258-84-0
Pristimerin(NSC 99281);(9b,13a,14b,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tertraen-29-oic acid methyl ester; Celastrol methyl ester; (9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid methyl ester; 3-hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid, methyl ester
扁塑藤素
C12310
38748-32-2
Triptolide(TPL);PG490 ; PG 490 ; PG-490;(3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-3b,4,4a,6,6a,7a,7b,8b,9,10-Decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1(3H)-one
雷公藤甲素; 雷公藤內(nèi)酯醇; 雷公藤多甙
C17228
38647-10-8
Tripdiolide;Triptodiolide
雷公藤乙素;雷公藤羥內(nèi)酯;雷公藤內(nèi)酯二醇
C16808
37239-51-3
Wilfordine;Wilfordin;(8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-10,13,22,23-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-18,21-dihydroxy-8,18,21-trimethyl-,8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione;8,11-Epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione,10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-18,21-dihydroxy-8,18,21-trimethyl-,(8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-
雷公藤定堿;雷公藤堿;雷公藤定
C12391
37239-47-7
Wilforgine;Wilforgin; Evonimine, 8-(acetyloxy)-O2-deacetyl-8-deoxo-O2-(3-furanylcarbonyl)-, (8α)-;3-Furancarboxylic acid, 10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-21-hydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridin-14-yl ester, (8R,9R,10R,11S,12S,13R,14R,15S,18S,21S,22S,23R)-;(8alpha)-8-(Acetyloxy)-O2-deacetyl-8-deoxo-O2-(3-furanylcarbonyl)- evonimine Wilforgin; 3-Furancarboxylic acid (8R,9R,10R,11S,12R,13R,14R,15S,18S,21S,22S,23R)-10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-21-hydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridin-14-yl ester;AIDS088959; AIDS-088959;BRN 0078231; Evonimine, 8-(acetyloxy)-O(sup 2)-deacetyl-8-deoxo-O(sup 2)-(3-furanylcarbonyl)-, (8-alpha)-
雷公藤吉堿;雷公藤晉堿;雷公藤精堿
C12392
11088-09-8
Wilforine;26-Deoxywilfordine; Evonimine, 8-(acetyloxy)-O2-benzoyl-O2-deacetyl-8-deoxo-, (8α)-;8,11-Epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione, 10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-21-hydroxy-8,18,21-trimethyl-, (8R,9R,10R,11S,12S,13R,14R,15S,18S,21S,22S,23R)-;(8R,9R,10R,11S,12S,13R,14R,15S,18S,21S,22S,23R)-10,13,22,23-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-21-hydroxy-8,18,21-trimethyl-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione
雷公藤次堿
C16807
37239-48-8
Wilfortrine;Wilfortrin;3-Furancarboxylic acid,(8R,9R,10R,11S,12R,13R,14R,15S,21S,22S,23R)-10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-18,21-dihydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridin-14-ylester
雷公藤春堿
C16809
345954-00-9
Wilfornine A;8,11-Epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione, 10,13,14,22,23-pentakis(acetyloxy)-12-[(acetyloxy)methyl]-18-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-21-hydroxy-8,18,21-trimethyl-, (8R,9R,10R,11S,12R,13R,14R,15S,21S,22S,23R)-
雷公藤寧堿 A
C16754
168009-85-6
Triptonine B; Triptonine B (Tripterygium wilfordii); (-)-Triptonine B; 18-O-(3-Furoyl)wilfortrine; Wilfortrine 26-(3-furoate); 3-Furancarboxylic acid, 10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-21-hydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H[1,9]dioxacyclooctadecino[4,3-b]pyridine-14,18-diylester, (8R,9R,10R,11S,12R,13R,14R,15S,18R,21S,22S,23R)-
18-O-(3-糠酰)雷公藤春堿
C12393
84104-71-2
Wilforlide A
雷公藤內(nèi)酯甲;雷公藤酯甲
C12311
38647-11-9
Triptonide;(3bS,4aS,5aS,6aS,7aS,7bS,8aS,8bS)-6a-Isopropyl-8b-methyl-3b,4,4a,7a,7b,8b,9,10-octahydrotrisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1,6(3H,6aH)-dione;NSC 165677;  PG 492
雷公藤內(nèi)酯酮; 雷藤酮
C10649
107316-88-1
Demethylzeylasteral; (9beta,13alpha,14beta,20alpha)-2,3-Dihydroxy-9,13-dimethyl-6,23-dioxo-24,25,26-trinoroleana-1,3,5(10),7-tetraen-29-oic acid
去甲澤拉木醛
C12312
74285-86-2
Triptophenolide;(+)-Triptophenolide; Hypolide; (3bR,9bS)-3b,4,5,9b,10,11-Hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)phenanthro[1,2-c]furan-1(3H)-one
雷酚內(nèi)酯; 山海棠素

 

凱立德生物醫(yī)藥技術(shù)(上海)有限公司
電話:021-58180488
400-968-3299
Email:
 sales@Biochemleader.com         

相關(guān)新聞資訊
  • 2026/01/15
    一、開(kāi)篇引言:將原子視作“夜間奔跑的熒光手環(huán)”?想像一下,如果給某個(gè)原子戴上一只閃閃發(fā)亮、又不會(huì)影響它跑步姿勢(shì)的“夜跑手環(huán)”,我們就能在黑暗里一路追隨它的足跡。同位素標(biāo)記物就是這樣一只“原子手環(huán)”——它們和普通原子化學(xué)性質(zhì)幾乎一模一樣,卻帶著獨(dú)一無(wú)二的“亮光”(放射性衰變或質(zhì)量差異),讓科學(xué)家在生命代謝、農(nóng)田施肥、食品溯源的“黑夜”里精準(zhǔn)追蹤目標(biāo)分子的去向。?二、先認(rèn)標(biāo)簽:穩(wěn)定派 VS 放射派??
  • 2025/10/28
    干細(xì)胞和抗體偶聯(lián)藥物(ADC)的研究是當(dāng)前生物醫(yī)藥領(lǐng)域的兩大前沿方向。干細(xì)胞研究為組織修復(fù)和再生醫(yī)學(xué)提供了新的可能性,而抗體偶聯(lián)藥物則為癌癥治療帶來(lái)了新的希望。本文將深入探討干細(xì)胞、Wnt信號(hào)通路以及抗體偶聯(lián)藥物(ADC)的研究進(jìn)展及其在未來(lái)的應(yīng)用前景。一、干細(xì)胞:生命的基礎(chǔ)?1. 干細(xì)胞的定義與特性干細(xì)胞是一類具有自我更新和多向分化潛能的細(xì)胞群體,能夠在不同器官內(nèi)持續(xù)維持組織的穩(wěn)態(tài)和修復(fù)損傷。干
  • 2024/12/31
    在人類抵御外界侵襲的漫長(zhǎng)征程里,免疫系統(tǒng)宛如一座堅(jiān)不可摧的堡壘,守護(hù)著我們的健康。而抗體,無(wú)疑是這座堡壘中訓(xùn)練有素、戰(zhàn)斗力爆表的精銳衛(wèi)士,依靠精準(zhǔn)打擊外來(lái)威脅的非凡本領(lǐng),時(shí)刻捍衛(wèi)著身體的安穩(wěn)。 一、抗體究竟是什么? 抗體,專業(yè)名稱叫免疫球蛋白(Ig),由 B 淋巴細(xì)胞分泌產(chǎn)生,本質(zhì)上是一類蛋白質(zhì)。當(dāng)病原體大張旗鼓地入侵人體,巨噬細(xì)胞會(huì)率先行動(dòng),把病原體分解,從中提取出抗原,遞交

查看更多

商家暫時(shí)不對(duì)外公布

凱立德生物
榆社县| 金寨县| 五大连池市| 濉溪县| 仁寿县| 潜江市| 道孚县| 扶风县| 沅陵县| 英超| 金沙县| 西华县| 龙川县| 赣榆县| 共和县| 五家渠市| 调兵山市| 潞西市| 诏安县| 米脂县| 兰州市| 尤溪县| 镇雄县| 嫩江县| 安岳县| 大港区| 茶陵县| 射阳县| 百色市| 广水市| 镇远县| 西青区| 土默特左旗| 香格里拉县| 长丰县| 彭阳县| 讷河市| 全南县| 茂名市| 湖州市| 资溪县|